Search hospitals

>

Ontario

>

LONDON

Children's Hospital

Claim this profile

LONDON, Ontario N6A 5W9

Global Leader in Acute Lymphoblastic Leukemia

Global Leader in Cancer

Conducts research for Crohn's Disease

Conducts research for Childhood Leukemia

Conducts research for Ulcerative Colitis

158 reported clinical trials

19 medical researchers

Photo of Children's Hospital in LONDONPhoto of Children's Hospital in LONDONPhoto of Children's Hospital in LONDON

Summary

Children's Hospital is a medical facility located in LONDON, Ontario. This center is recognized for care of Acute Lymphoblastic Leukemia, Cancer, Crohn's Disease, Childhood Leukemia, Ulcerative Colitis and other specialties. Children's Hospital is involved with conducting 158 clinical trials across 355 conditions. There are 19 research doctors associated with this hospital, such as Shayna M. Zelcer, Terry Ponich, MD, FRCPC, Matthew Weir, MD, and Adam Power, MD.

Area of expertise

1

Acute Lymphoblastic Leukemia

Global Leader

Children's Hospital has run 18 trials for Acute Lymphoblastic Leukemia. Some of their research focus areas include:

Stage II
Stage IV
Stage III
2

Cancer

Global Leader

Children's Hospital has run 16 trials for Cancer. Some of their research focus areas include:

Stage IV
Stage I
Stage II

Top PIs

Clinical Trials running at Children's Hospital

Brain Tumor

Wilms Tumor

Testicular cancer

Neuroblastoma

Acute Lymphoblastic Leukemia

Crohn's Disease

Ovarian Carcinoma

Ovarian Tumors

Testicular Carcinoma

Ovarian Choriocarcinoma

Image of trial facility.

DAY101 vs. Chemotherapy

for Pediatric Brain Cancer

This trial is testing tovorafenib, a medication given alone, in children with a specific type of brain tumor. The drug works by blocking a protein that helps cancer cells grow.

Recruiting

2 awards

Phase 3

Image of trial facility.

Health Information Collection

for Childhood Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

Recruiting

1 award

N/A

10 criteria

Image of trial facility.

Lower Radiotherapy Dose

for Brain Tumors

This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in treating children with central nervous system (CNS) germinomas. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Researchers want to see if lowering the dose of standard radiotherapy (RT) after chemotherapy can help get rid of CNS germinomas with fewer long-term side effects.

Recruiting

1 award

Phase 2

10 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Children's Hospital?